Results 271 to 280 of about 234,696 (305)

Human CMV vaccine trials: What if CMV caused a rash?

Journal of Clinical Virology, 2008
There are no apparent biologic obstacles to immunization against fetal/placental infection with cytomegalovirus (CMV), and vaccine candidates have been developed. The major obstacles for a human CMV vaccine are difficulties associated with the design and execution of efficacy trials.
openaire   +2 more sources

Clinical Features of CMV-Associated Anterior Uveitis

Ocular immunology and inflammation, 2018
N. S. Chan, S. Chee, L. Caspers, B. Bodaghi   +3 more
semanticscholar   +1 more source

Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation

Cellular and Molecular Immunology, 2022
Xu-Ying Pei, Xiang-Yu Zhao, Meng Lv
exaly  

CMV

2006
  +4 more sources

DIAGNOSIS OF CMV

The Pediatric Infectious Disease Journal, 1999
openaire   +2 more sources

New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant/Refractory Disease

Infectious Diseases and Therapy, 2022
Camille N Kotton, Nassim Kamar, Kamar Nassim   +2 more
exaly  

CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor

Transplantation, 2017
T. Schachtner, M. Stein, P. Reinke
semanticscholar   +1 more source

CMV

2012
Shannon A. Ross, Suresh B. Boppana
openaire   +1 more source

Linking CMV Serostatus to Episodes of CMV Reactivation Following Lung Transplantation by Measuring CMV-Specifi cCD8+ T-Cell Immunity

American Journal of Transplantation, 2008
G P Westall, Nicole A Mifsud, T Kotsimbos   +2 more
exaly  

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Blood, 2013
Emily Blyth, Leighton Clancy, Renee Simms   +2 more
exaly